Hospital alert: CMS hospital transparency requirements in effect January 1, 2019

By Yvonne Puig (US) and Jeff Wurzburg (US) on December 31, 2018 Posted in Regulatory

On January 1, 2019, all hospitals are required to make public a list of their standard charges. As a reminder, Section 2718(e) of the Public Health Service Act, as enacted by the Affordable Care Act, requires: “each hospital operating within the United States” to “make public (in accordance with guidelines developed by the Secretary) a … Continue reading

CMS FY 2019 IPPS and LTCH PPS proposed rule targets interoperability, transparency and burden reductions

By Jeff Wurzburg (US) on April 27, 2018 Posted in Regulatory

On April 24, the Centers for Medicare & Medicaid Services (CMS) released its fiscal year (FY) 2019 inpatient prospective payment system (IPPS) and long-term care hospital prospective payment system (LTCH PPS) proposed rule. CMS proposes to reduce regulatory burdens for inpatient hospitals and increase price transparency and better data sharing between hospitals and other providers … Continue reading

Pharmaceutical Cost Transparency Act of 2015 introduced in the New York State Senate

By Carol Poindexter (US) on May 21, 2015 Posted in Transparency

Under the auspices of increased transparency, on May 13, 2015, state senator Ruben Diaz (D-NY) introduced the “Pharmaceutical Cost Transparency Act of 2015” [Bill 5338] to the New York State Senate. The legislative intent is “to make pharmaceutical pricing as transparent as the pricing in other sectors of the health care industry.” If passed, the … Continue reading